Lung Cancer Screening Track

27th November – 15:45 – 17:00 – Session III
Education Track

Smoking cessation activity and Lifestyle within the screening

Beside the assessment of potential economic impact to start implementation, established guidelines to assure effective and safe implementation of lung cancer screening in Europe, are required.

A board of experts has been instituted and endorsed by the European Commission to create such guidelines to address the following issues:

Issues Addressed:

  • Screening Economical impact and cost effectiveness analysis (which is the economical impact of lung cancer screening for one European public health care system ?)
  • Training and education impact (what is the best program of education and training of screening team members and the impact?)
  • Dissemination (How can we teach the population on the importance of prevention and screening to improve informed consent and decision capability of high risk individuals?)

Chair

Claudia I. Henschke

Claudia I. Henschke

Clinical Professor Radiology, Icahn School of Medicine at Mount Sinai, New York, US

Panel

Collateral benefit and findings of LDCT information

 Joseph Shemesh

Joseph Shemesh

Director of the Shibat Medical Screening, Sheba Medical Center, Israel

Smoking cessation activity and lifestyle education

Dr Rachael Murray

Dr Rachael Murray

Associate Professor in Health Policy, Faculty of Medicine & Health Sciences

How we can integrate chemoprevention study within screening programs

Ugo Pastorino

Ugo Pastorino

Thoracic Surgery, National Cancer Institute

Collateral benefit of LDCT screening: emphysema and COPD

 David-Baldwin

David Baldwin

Honorary Professor of Medicine and Consultant Physician, University of Nottingham

Screening cost-effectiveness analysis and how to adapt the impact of screening in different European

Simone Ghislandi

Simone Ghislandi

CERGAS and Department of Social and Political Sciences Bocconi University, Milan, Italy

Discussion: Q&A